A new slate of mass tort cases is gathering momentum in Philadelphia’s Complex Litigation Center as the matters that dominated its docket in recent years approach resolution. The two largest matters in the program—one of the country’s busiest hubs for mass tort litigation—are in various stages of winding down, and in recent months three new mass tort cases have emerged.

The vena cava and Risperdal litigation remain the largest two programs in the Complex Litigation Center, according to case listings on the court’s website. But Feldman & Pinto’s Rosemary Pinto, who serves as plaintiffs counsel in both matters, says parties are working to resolve the remaining cases in both programs.